Keywords: humannonspecific lipid transfer protein/peroxisomes/Zellweger syndrome/neonataladrenoleukodystrophy ABSTRACT. The biosynthesis and intracellular localization of nonspecific lipid transfer protein (nsLTP) in control humansubjects and in patients with peroxisome-deficient disorders were investigated. The molecular mass of human nsLTP was indistinguishable from that of rat nsLTP (13 kDa) by an immunoblot analysis. Intracellular localization was identical with that of catalase, a marker enzyme of peroxisomal matrix, by a double immunofluorescence study. The nsLTP was deficient in liver tissues or fibroblasts from patients with peroxisomedeficient disorders such as Zellweger syndrome and neonatal adrenoleukodystrophy (ALD). Pulse-chase experiments showed that nsLTPwas synthesized as a large precursor in both the control and Zellweger fibroblasts. However, the processing to the 13 kDa mature protein was disturbed and the degradation was rapid in Zellweger fibroblasts. After somatic cell fusion using Zellweger fibroblasts from different genetic groups, the processing was normalized. These results suggest that the biosynthesis and localization of humannsLTPare similar to those of rat nsLTP and that the defect of nsLTP in peroxisome-deficient disorders is a phenomenonsecondary to an abnormal transport mechanism of peroxisomal proteins. The defect of nsLTP may play an important role in metabolic disturbances in bile acid synthesis and steroidogenesis in peroxisome-deficient disorders. and glycosphingolipids in vitro (2). Since peroxisomes oxidize 3a,7a,12a,trihydroxy-5/3-cholestanoic acid to cholic acid (8), and part of the 3-hydroxy-3-methylglutaryl coenzyme A reductase, a rate-limiting enzyme of cholesterol formation, is located in peroxisomes (9), nsLTP is thought to play an important role in these metabolic events.
ABSTRACT. The biosynthesis and intracellular localization of nonspecific lipid transfer protein (nsLTP) in control humansubjects and in patients with peroxisome-deficient disorders were investigated. The molecular mass of human nsLTP was indistinguishable from that of rat nsLTP (13 kDa) by an immunoblot analysis. Intracellular localization was identical with that of catalase, a marker enzyme of peroxisomal matrix, by a double immunofluorescence study. The nsLTP was deficient in liver tissues or fibroblasts from patients with peroxisomedeficient disorders such as Zellweger syndrome and neonatal adrenoleukodystrophy (ALD). Pulse-chase experiments showed that nsLTPwas synthesized as a large precursor in both the control and Zellweger fibroblasts. However, the processing to the 13 kDa mature protein was disturbed and the degradation was rapid in Zellweger fibroblasts. After somatic cell fusion using Zellweger fibroblasts from different genetic groups, the processing was normalized. These results suggest that the biosynthesis and localization of humannsLTPare similar to those of rat nsLTP and that the defect of nsLTP in peroxisome-deficient disorders is a phenomenonsecondary to an abnormal transport mechanism of peroxisomal proteins. The defect of nsLTP may play an important role in metabolic disturbances in bile acid synthesis and steroidogenesis in peroxisome-deficient disorders. Nonspecific lipid transfer protein (nsLTP), a compound identical with sterol carrier protein 2, is localized in the matrix of rat liver peroxisomes (18). Although the physiological role of nsLTPis unclear, this protein appears to function at several steps in the metabolism of cholesterol (13) . The nsLTP transfers phospholipids, cholesterol and glycosphingolipids in vitro (2) . Since peroxisomes oxidize 3a,7a,12a,trihydroxy-5/3-cholestanoic acid to cholic acid (8) , and part of the 3-hydroxy-3-methylglutaryl coenzyme A reductase, a rate-limiting enzyme of cholesterol formation, is located in peroxisomes (9), nsLTP is thought to play an important role in these metabolic events.
The intracellular localization of nsLTPwas analyzed by several investigators. Van (4) and multiple metabolic disturbances, including defects of peroxisomal /5-oxidation enzymes (15) , the first step of plasmalogen biosynthesis (7), phytanic acid oxidation (12) and others (see reference 22). Although accumulation of bile acid intermediates in patients with Zellweger syndrome and neonatal ALD (6) was considered to be mainly caused by defects in peroxisomal /3-oxidation enzymes, the possible role of defective nsLTP in these metabolic disturbances must be given attention.
Decreased formation of plasmalogen (7), and adrenal dysfunction in these patients (5) (sample buffer), boiled for 3min and subjected to SDS/PAGE (12%) (1 1). After western blotting (16), blocking was done with 5% bovine serum albumin, and the preparation was incubated with anti-rat nsLTP IgG or anti-human catalase IgG, then reincubated with alkaline phosphatase con- Pulse-chase experiments. Fibroblasts from a patient with 
RESULTS
Immunoblot analysis. HumannsLTPwas detected in the liver extracts from the control (Fig. 1A , lanes 3 and 8) and the patient with a probable deficiency of peroxisomal /?-oxidation enzyme (lane 7) using anti-rat nsLTP IgG. The molecular mass (about 13 kDa) was indistinguishable from that of purified rat nsLTP (lane 2). In the liver from the patients with Zellweger syndrome and neonatal ALD, nsLTP was hardly detectable (lanes 4, 5 and 6). A 60 kDa protein with a molecular mass similar to that of catalase (lane 1, stained with anti-human catalase IgG) and two smaller bands (about 30 kDa) were detected in both the control and the patients. Antibody against nsLTP did not cross-react with the purified catalase (data not shown). Catalase was present in tissues from both the control and the patients (Fig. IB) . Anti-catalase IgG did not cross-react with the purified nsLTP (Fig. IB, lane 2) . Immunofluorescence staining. In the control fibroblasts, nsLTP was stained in a granular pattern ( Fig.  2A) , similar to that seen with catalase, a marker enzyme of the peroxisomal matrix (Fig. 2D ). This staining pattern differed from those of other organelles such as mitochondria and lysosomes (data not shown). In fibroblasts from the patient with neonatal ALD, nsLTP was not detected in the majority of cells. However, it was detected in a very small number of cells (less than 10%) Fig. 3 . Double immunofluorescence staining of fused fibroblasts. Zellweger fibroblasts from two genetically different groups were fused with polyethylene glycol and cultured on a cover slip for 3 days, and a double immunofluorescence staining was carried out. A: stained with guinea pig anti-rat nsLTP IgG and rhodamine-conjugated goat antj-guinea pig IgG; B: stained with rabbit anti-human catalase IgG and FITC-conjugated goat anti-rabbit IgG. Bar=10^m.
( Fig. 2B) , a finding which agreed well with the result of catalase staining (Fig. 2E) . In fibroblasts from the patient with Zellweger syndrome, nsLTP was hardly detected either in peroxisomal granules or in the cytosol (Fig. 2C) . Catalase was present in the cytosol of Zellweger fibroblasts (Fig. 2F ).
After cell fusion using fibroblasts from two genetically different
Zellweger patients, peroxisomes were formed and visualized by a double immunofluorescence staining using guinea pig anti-rat nsLTP and rabbit anti-human catalase. Localization of nsLTP (Fig. 3A) and catalase (Fig. 3B) was very similar. The results using control fibroblasts or neonatal ALDcells also support the localization of nsLTPin peroxisomes (data not shown).
Pulse-chase experiments. In the control fibroblasts, a 60 kDa protein (open arrowhead), a precursor protein (arrow) and a thick mature nsLTP were detected in the pulse experiment (Fig. 4, lane 3) . These bands disappeared when 10^g of rat nsLTP was added during the immunoprecipitation.
(lane 1, same sample as lane 3). The molecular masses of the precursor (about 14.5 kDa) and the mature protein (about 13 kDa) were considered to be idetical with those of rat proteins. The precursor is thought to be rapidly processed to the mature protein. In the chase experiments, the precursor disappeared and the matureprotein wasstable evenafter a 72 h chase. A 60 kDa protein was faintly detected in a 6 h chase (lane 4), then it disappeared with a 24 h chase.
The competition experiment (lane 2, same sample as lane 4) indicated that this is not catalase since the bands of 60 kDa protein and mature nsLTP did not disappear with the addition of catalase. The precursor of nsLTP was synthesized in fibroblasts from the patients with Zellweger syndrome (Fig.  5A) . However, the newly synthesized nsLTP precursor could not be processed to the mature protein. After a 6 h chase, the precursor rapidly degraded and the mature protein was not detected. On the other hand, the precursor was completely processed to the mature protein in catalase -+ the complemented fused cells which were selected by P12/UVkilling, albeit the amount of the mature protein in the pulse being less than that of the control fibroblasts. The 60kDa protein was detected after a 6h chase in both the patient and the complemented fused cells. Synthesis and processing of mitochondrial enoylCoAhydratase were normal throughout (Fig. 5B) .
DISCUSSION
In case of biosynthesis and intracellular localization of nsLTP in the rat liver, it was elucidated that nsLTP was synthesized as a large precursor (14.5 kDa) on free polysomes, transported into peroxisomes and presumably proteolytically processed to a 13 kDa mature protein (3). The nsLTP was determined to be localized mainly in the peroxisomal matrix by immunoelectron microscopic examinations and immunoblot analysis (18) .
In the present work, we obtained evidence for the biosynthesis and intracellular localization of human nsLTP. HumannsLTP is also synthesized as a precursor which is about 1.5kDa larger than the mature nsLTP, and it seems to be localized in peroxisomes from the data of immunofluorescence studies. Wealso have evidence for the localization of humannsLTP in peroxisomes by immunoelectronmicroscopic examinations (data not shown). As in the case of rat (3), the precursor is completely processed to its mature form within 1 h. The mature nsLTP remains stable for at least 72 h. The relationship between nsLTP and 60 kDa protein remains to be elucidated. Limited proteolysis of 60 kDa protein showed that this is not a oligomer of nsLTP(3). However, the result of competition experiment suggests that 60 kDa protein may be a nsLTP-related protein. shown in rat experiments, nsLTPmay function in cholesterol metabolism. Although the defect of biosynthesis of bile acids in patients without peroxisomes is considered to be mainly caused by defects in peroxisomal /3-oxidation enzymes, the defect of nsLTP maydecrease transport of bile acid precursors into the peroxisomes.
Administration of adrenocorticotropin increases the number of peroxisomes in the guinea pig adrenal gland (1) and induces nsLTP in rat adrenocortical cells (17). Adrenal dysfunction or low reaction of steroid hormonesagainst adrenocorticotropin in peroxisome-deficient disorders, as possibly related to the defective biosynthesis of nsLTP, deserves further attention.
